Your browser doesn't support javascript.
loading
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours.
Hong, David S; Kang, Yoon-Koo; Borad, Mitesh; Sachdev, Jasgit; Ejadi, Samuel; Lim, Ho Yeong; Brenner, Andrew J; Park, Keunchil; Lee, Jae-Lyun; Kim, Tae-You; Shin, Sangjoon; Becerra, Carlos R; Falchook, Gerald; Stoudemire, Jay; Martin, Desiree; Kelnar, Kevin; Peltier, Heidi; Bonato, Vinicius; Bader, Andreas G; Smith, Susan; Kim, Sinil; O'Neill, Vincent; Beg, Muhammad S.
Afiliación
  • Hong DS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. dshong@mdanderson.org.
  • Kang YK; Asan Medical Center, Seoul, South Korea.
  • Borad M; Mayo Clinic Cancer Center, Scottsdale, AZ, USA.
  • Sachdev J; Scottsdale Healthcare Research Institute, Scottsdale, AZ, USA.
  • Ejadi S; University of California Irvine Medical Center, Orange, CA, USA.
  • Lim HY; Samsung Medical Center, Seoul, Korea.
  • Brenner AJ; The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Park K; Samsung Medical Center, Seoul, Korea.
  • Lee JL; Asan Medical Center, Seoul, South Korea.
  • Kim TY; Seoul National University Hospital, Seoul, South Korea.
  • Shin S; Severance Hospital, Seoul, South Korea.
  • Becerra CR; Texas Oncology-US Oncology-Baylor University Medical Center, Dallas, TX, USA.
  • Falchook G; Sarah Cannon Research Institute at HealthONE, Denver, CO, USA.
  • Stoudemire J; Mirna Therapeutics, Austin, TX, USA.
  • Martin D; Mirna Therapeutics, Austin, TX, USA.
  • Kelnar K; Mirna Therapeutics, Austin, TX, USA.
  • Peltier H; Mirna Therapeutics, Austin, TX, USA.
  • Bonato V; Mirna Therapeutics, Austin, TX, USA.
  • Bader AG; Mirna Therapeutics, Austin, TX, USA.
  • Smith S; Mirna Therapeutics, Austin, TX, USA.
  • Kim S; Mirna Therapeutics, Austin, TX, USA.
  • O'Neill V; Mirna Therapeutics, Austin, TX, USA.
  • Beg MS; The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Br J Cancer ; 122(11): 1630-1637, 2020 05.
Article en En | MEDLINE | ID: mdl-32238921

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: MicroARNs / Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: MicroARNs / Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos